Your session is about to expire
← Back to Search
Behavioral Intervention
Computerized Memory Training for Mild Cognitive Impairment (COMET Trial)
N/A
Waitlist Available
Led By Alexander C Conley, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will use a computerized brain training program to see if it can improve memory in people with Mild Cognitive Impairment.
Who is the study for?
This trial is for adults aged 55-85 with Mild Cognitive Impairment (MCI), who have memory concerns but not severe dementia or Alzheimer's. Participants must be in good health, not pregnant, and fluent in English. They need a study partner available to assist during the study.
What is being tested?
The trial tests a computer program designed to improve memory by using exercises that stimulate brain plasticity. It aims to see if regular use of this cognitive training can enhance memory function in those with MCI.
What are the potential side effects?
Since the intervention involves cognitive exercises on a computer, side effects are minimal but may include eye strain or headache from screen time, and potential frustration or stress related to the tasks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluate completion rates of nCCR
Evaluate visit duration throughout nCCR treatment
Evaluate visit frequency throughout nCCR treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Neuroplasticity-based Computerized Cognitive RemediationExperimental Treatment1 Intervention
Participants will receive a 45-hour of Neuroplasticity-based Computerized Cognitive Remediation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neuroplasticity-based Computerized Cognitive Remediation
2020
N/A
~30
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,801 Total Patients Enrolled
Alexander C Conley, PhDPrincipal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
7 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your score on the Geriatric Depression Scale is 14 or lower.You have good enough eyesight and hearing to do the tests that measure your brain function.You have had severe depression, bipolar disorder, or other mental health conditions that might make it hard for you to follow the study's instructions.You have been diagnosed with schizophrenia according to the DSM V criteria.You have had a problem with drinking alcohol or using drugs in the past 2 years.You do not have severe memory and thinking problems that would make the doctor think you have Alzheimer's disease.
Research Study Groups:
This trial has the following groups:- Group 1: Neuroplasticity-based Computerized Cognitive Remediation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger